← Back
Data updated: Jul 17, 2026
CENT PHARMS
Generics Pharmaceuticals
CENT PHARMS is a generic drug manufacturer with 10 FDA-approved products.
1947
Since
10
Drugs
-
Trials
0
New Drugs (2yr)
CENT PHARMS's Key Drugs
CENT PHARMS's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
No active drugs
CENT PHARMS's Recent FDA Approvals
New NDA/BLA approvals for CENT PHARMS over the last two years — novel drugs only, excluding generics and label supplements.
No recent approvals
CENT PHARMS's Therapeutic Areas
Disease areas where CENT PHARMS has approved drugs and an active pipeline. Weighted by commercial stage — approved drugs count most, then late-stage trials.
No indication data
CENT PHARMS Pipeline Snapshot
Active clinical trials for CENT PHARMS across all therapeutic areas, from ClinicalTrials.gov.
No active pipeline data available
Pro Expected Approvals & Milestones
Loading detailed analysis...
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Active trial monitoring
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Unlock Full Intelligence
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 1947-10-17
- Latest
- 1999-11-29
- Applications
- 10